© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - The Best in Oncology Research
Posted 29th September 2016

The Best in Oncology Research

Founded in 1997, MedSource is a full-service niche clinical research organisation (CRO), specialising in oncology programs and other complex clinical trials.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

The Best in Oncology Research
Image

Founded in 1997, MedSource is a full-service niche clinical research organisation (CRO), specialising in oncology programs and other complex clinical trials. We have participated in more than 700 clinical trials globally, with over 200 of them occurring in the area of oncology. MedSource’s efforts support biopharmaceutical clients who conduct complex trials in the most challenging disease states. The firm’s experience encompasses a range of therapeutic areas, product types, clinical trial phases and study designs.

Over the years, MedSource’s services have expanded to include clinical monitoring, clinical project management, regulatory affairs and submissions, quality assurance (QA) auditing, study startup services, feasibility and site selection, data management, biostatistics, safety reporting, as well as medical monitoring.

MedSource’s goal is for our clients to return to us when they need high-quality clinical trial support. It is our role to be a trusted advisor and to act with our clients’ best interests in mind. Our clients trust that we will get the job done, with minimal management required.

Each time MedSource undertakes a new client, our approach remains the same as it has been for the last 19 years, we approach every opportunity with a customised solution.
In regards to MedSource’s staff, they are passionate, genuine and critically focused on integrity and results. The team you meet at the start are the ones who work on your project. We are candid and transparent about all of our processes, and we provide line-item bids, so you see everything up front.

Going forward, MedSource are very excited about our prospects for the future and we are keen to increase the number of services we currently offer. With 6 locations throughout the US and Europe, we are prepared to handle our clients’ complex clinical trials.

Company: MedSource

Name: Eric Lund

Web: www.medsource.com

Address: 16902 El Camino Real, Suite 1A Houston, TX 77058 USA

Telephone: 1 (281) 286 200

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
How to Create an Outstanding Branding Strategy in 2023
News
02/03/2023How to Create an Outstanding Branding Strategy in 2023

If you want to survive in a competitive market, you need to carefully think about your branding strategy. Fortunately, many big brands can afford to spend money on different strategies, but this isn’t the case for all brands.

Read Full PostRead - Eye Icon
Six Important Tips to Build Local Awareness for Your Brand
News
04/09/2023Six Important Tips to Build Local Awareness for Your Brand

Business branding is not a new concept for local businesses. Every business wants to enhance the overall perception of their brand, product, or service. However, it can be a hard endeavor to achieve when you have so much competition around you. In such circums

Read Full PostRead - Eye Icon
Entertainment and Media: The Speeding Edge of the Digital Revolution Package
Innovation
19/10/2015Entertainment and Media: The Speeding Edge of the Digital Revolution Package

Founded in 2014, Dunaud Clarenc Combles & Associes brings together private and public experience and a culture of industry expertise and customised consulting, with an identity and a reputation formed through our work in the areas of litigation, institutional

Read Full PostRead - Eye Icon
Building upon Success
Innovation
20/06/2017Building upon Success

Most Outstanding for Restoration Architecture 2017 award winner NFA architects is an established and experienced practice formed of a senior director with dedicated architects, designers and technologists based in Kent. We interviewed the firm’s Nick Farnell

Read Full PostRead - Eye Icon
Saga Welcomes Osborne’s Inheritance Tax Reforms
Finance
09/07/2015Saga Welcomes Osborne’s Inheritance Tax Reforms

In a poll of more than 10,000 over 50s two thirds (65%) thought that the main family home should be excluded from inheritance tax calculations.

Read Full PostRead - Eye Icon
LV= Comments on UK Inflation Rate
Finance
25/03/2015LV= Comments on UK Inflation Rate

The UK's inflation rate fell to 0% in February 2015 from 0.3% in January.

Read Full PostRead - Eye Icon
The Findis Group Acquires Desamais Distribution
M&A
31/07/2015The Findis Group Acquires Desamais Distribution

The Findis Group Acquires Desamais Distribution

Read Full PostRead - Eye Icon
Why Continuity and Succession Planning is Crucial for Businesses Right Now
Legal
21/10/2020Why Continuity and Succession Planning is Crucial for Businesses Right Now

Coronavirus has created many challenges for businesses and an area of discussion that has rapidly escalated in importance is around protection. Protection should always be an area of priority for a business, but the situation we find ourselves in has understan

Read Full PostRead - Eye Icon
Why You Should Choose Professional iPhone Repair Services
News
09/09/2024Why You Should Choose Professional iPhone Repair Services

Why You Should Choose Professional iPhone Repair Services What do you do when your iPhone starts malfunctioning? How can you ensure it gets the best care without risking further damage? Choosing professional iPhone repair services is the most brilliant move fo



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow